LDS/Medical Tests/FKBP14 Gene Mutation Analysis

FKBP14 Gene Mutation Analysis

FKBP14 gene is located on chromosome 7 at position 14.3 that codes for a structural protein named FKBP prolyl isomerase 14. This protein is a member of the peptidyl-prolyl cis-trans isomerases and is involved in protein assembly and trafficking. It is found in the endoplasmic reticulum (ER), where FKBP prolyl isomerase 14 is thought to assist with protein folding of procollagens. Procollagens are complex molecules found in the spaces between cells (the extracellular matrix) that add strength, support, and elasticity to organs and tissues throughout the body. FKBP prolyl isomerase 14 may also play a role in processing other components of the extracellular matrix.

Mutations of FKBP14 are associated with autosomal recessive Kyphoscoliotic EDS w/myopathy & neurosensory hearing loss. The syndrome is characterized by severe muscle hypotonia at birth, progressive scoliosis, joint hypermobility, hyperelastic skin, myopathy, sensorineural hearing impairment, and normal pyridinoline excretion in urine. These symptoms are brought about by a loss of FKBP prolyl isomerase 14, which results in a disruption of endoplasmic reticulum activities and extracellular matrix organization which directly or indirectly affects connective tissue development and differentiation.

  • Molecular confirmation of kyphoscoliosis Ehlers-Danlos syndrome
  • Carrier identification in asymptomatic family members of a proband with kyphoscoliosis Ehlers-Danlos syndrome

Normal:

  • No biallelic mutation or pathogenic variants in FKBP14 gene

Abnormal:

  • Biallelic mutation or pathogenic variants in FKBP14 gene. Mutation may be small intragenic deletions/insertions and missense, nonsense and splice variants variants or deletions/duplications.

Negative for mutations analyzed or no pathogenic variants of the FKBP14 gene detected

Perform sequencing by next generation sequencing or bidirectional sequence analysis or targeted analysis for pathogenic variant. If only one or no pathogenic variant is found, FKBP14 targeted deletion/duplication analysis is performed by multiplex ligation-dependent probe amplification to detect intragenic deletions or duplications.

Whole Blood (EDTA, Lavender top tube).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Ehlers-Danlos Syndrome Panel (multi Genes), Next-Generation Sequencing and Deletion/Duplication Analysis, Fluorescence in Situ Hybridization (FISH), immunohistochemical analysis, biochemical test from cultured fibroblasts, histopathological examination.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login